69 related articles for article (PubMed ID: 9513710)
21. Zearalenone Promotes Uterine Development of Weaned Gilts by Interfering with Serum Hormones and Up-Regulating Expression of Estrogen and Progesterone Receptors.
Song T; Zhou X; Ma X; Jiang Y; Yang W; Liu F; Liu M; Huang L; Jiang S
Toxins (Basel); 2022 Oct; 14(11):. PubMed ID: 36355982
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic mechanisms regulate sex-specific bias in disease manifestations.
Chlamydas S; Markouli M; Strepkos D; Piperi C
J Mol Med (Berl); 2022 Aug; 100(8):1111-1123. PubMed ID: 35764820
[TBL] [Abstract][Full Text] [Related]
23. Computational investigations of the binding mechanism of novel benzophenone imine inhibitors for the treatment of breast cancer.
Shtaiwi A; Adnan R; Khairuddean M; Khan SU
RSC Adv; 2019 Oct; 9(61):35401-35416. PubMed ID: 35541022
[TBL] [Abstract][Full Text] [Related]
24. Age-Associated Changes in Estrogen Receptor Ratios Correlate with Increased Female Susceptibility to Coxsackievirus B3-Induced Myocarditis.
Koenig A; Buskiewicz I; Huber SA
Front Immunol; 2017; 8():1585. PubMed ID: 29201031
[TBL] [Abstract][Full Text] [Related]
25. Identification of estrogen-responsive genes based on the DNA binding properties of estrogen receptors using high-throughput sequencing technology.
Ikeda K; Horie-Inoue K; Inoue S
Acta Pharmacol Sin; 2015 Jan; 36(1):24-31. PubMed ID: 25500870
[TBL] [Abstract][Full Text] [Related]
26. Dysregulation of estrogen receptor beta (ERβ), aromatase (CYP19A1), and ER co-activators in the middle frontal gyrus of autism spectrum disorder subjects.
Crider A; Thakkar R; Ahmed AO; Pillai A
Mol Autism; 2014; 5(1):46. PubMed ID: 25221668
[TBL] [Abstract][Full Text] [Related]
27. The dynamic structure of the estrogen receptor.
Kumar R; Zakharov MN; Khan SH; Miki R; Jang H; Toraldo G; Singh R; Bhasin S; Jasuja R
J Amino Acids; 2011; 2011():812540. PubMed ID: 22312471
[TBL] [Abstract][Full Text] [Related]
28. Tumorigenic effects of tamoxifen on the female genital tract.
Nasu K; Takai N; Nishida M; Narahara H
Clin Med Pathol; 2008; 1():17-34. PubMed ID: 21876648
[TBL] [Abstract][Full Text] [Related]
29. The regulation of MS-KIF18A expression and cross talk with estrogen receptor.
Zusev M; Benayahu D
PLoS One; 2009 Jul; 4(7):e6407. PubMed ID: 19636373
[TBL] [Abstract][Full Text] [Related]
30. Indirect regulation of PTH by estrogens may require FGF23.
Carrillo-López N; Román-García P; Rodríguez-Rebollar A; Fernández-Martín JL; Naves-Díaz M; Cannata-Andía JB
J Am Soc Nephrol; 2009 Sep; 20(9):2009-17. PubMed ID: 19628670
[TBL] [Abstract][Full Text] [Related]
31. Do Estrogen Receptor beta Polymorphisms Play A Role in the Pharmacogenetics of Estrogen Signaling?
Nott SL; Huang Y; Fluharty BR; Sokolov AM; Huang M; Cox C; Muyan M
Curr Pharmacogenomics Person Med; 2008 Dec; 6(4):239-259. PubMed ID: 19337586
[TBL] [Abstract][Full Text] [Related]
32. Gene expression profiling reveals that the regulation of estrogen-responsive element-independent genes by 17 beta-estradiol-estrogen receptor beta is uncoupled from the induction of phenotypic changes in cell models.
Li X; Nott SL; Huang Y; Hilf R; Bambara RA; Qiu X; Yakovlev A; Welle S; Muyan M
J Mol Endocrinol; 2008 May; 40(5):211-29. PubMed ID: 18434428
[TBL] [Abstract][Full Text] [Related]
33. Splicing potentiation by growth factor signals via estrogen receptor phosphorylation.
Masuhiro Y; Mezaki Y; Sakari M; Takeyama K; Yoshida T; Inoue K; Yanagisawa J; Hanazawa S; O'malley BW; Kato S
Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8126-31. PubMed ID: 15919818
[TBL] [Abstract][Full Text] [Related]
34. ERbeta Binds N-CoR in the Presence of Estrogens via an LXXLL-like Motif in the N-CoR C-terminus.
Webb P; Valentine C; Nguyen P; Price RH; Marimuthu A; West BL; Baxter JD; Kushner PJ
Nucl Recept; 2003 Jun; 1(1):4. PubMed ID: 12904255
[TBL] [Abstract][Full Text] [Related]
35. Estrogen receptors: structure, mechanisms and function.
Hewitt SC; Korach KS
Rev Endocr Metab Disord; 2002 Sep; 3(3):193-200. PubMed ID: 12215714
[No Abstract] [Full Text] [Related]
36. Crosstalk between the insulin-like growth factors and estrogens in breast cancer.
Yee D; Lee AV
J Mammary Gland Biol Neoplasia; 2000 Jan; 5(1):107-15. PubMed ID: 10791773
[TBL] [Abstract][Full Text] [Related]
37. Oestrogen and growth factor cross-talk and endocrine insensitivity and acquired resistance in breast cancer.
Nicholson RI; Gee JM
Br J Cancer; 2000 Feb; 82(3):501-13. PubMed ID: 10682656
[No Abstract] [Full Text] [Related]
38. Antiestrogens--tamoxifen, SERMs and beyond.
Dhingra K
Invest New Drugs; 1999; 17(3):285-311. PubMed ID: 10665480
[TBL] [Abstract][Full Text] [Related]
39. Estradiol repression of tumor necrosis factor-alpha transcription requires estrogen receptor activation function-2 and is enhanced by coactivators.
An J; Ribeiro RC; Webb P; Gustafsson JA; Kushner PJ; Baxter JD; Leitman DC
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15161-6. PubMed ID: 10611355
[TBL] [Abstract][Full Text] [Related]
40. Transcriptional activation by oestrogen receptors.
Parker MG
Biochem Soc Symp; 1998; 63():45-50. PubMed ID: 9513710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
